Itovebi 3 mg – DIN 02555476
Itovebi is Inavolisib 3 mg (tablet), sold in Canada. It is used for breast cancer. It is supplied by Hoffmann-LA Roche Limited. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Inavolisib 3 mg
- Brand
- Itovebi
- Strength
- 3 mg
- Used for
- Breast cancer
- Form
- Tablet
- Manufacturer
- Hoffmann-LA Roche Limited
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02555476
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Inavolisib used for?
Inavolisib is used for breast cancer.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
ITOVEBI, in combination with palbociclib and fulvestrant, is indicated for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant endocrine therapy.
From the FDA-approved label on DailyMed (published Apr 28, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02555476.
- It names Itovebi, Inavolisib 3 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Itovebi by Hoffmann-LA Roche Limited.
In Canada: PRESCRIPTION RECOMMENDED.
Ingredients
Active: Inavolisib